Literature DB >> 2071824

Endocrine pancreatic function in pheochromocytoma.

N Sicolo1, G Federspil, C B De Palo, R Vettor, C Martini, C Scandellari.   

Abstract

In six patients with pheochromocytoma oral glucose tolerance test (OGTT) and arginine test were carried out. Blood insulin and glucagon response were investigated. In subjects with adrenal tumor glycemic curve pattern was typical: a rapid and exaggerated increase of glycemia followed by an abrupt drop. Absolute insulinemic response to oral glucose was normal, but inappropriate to glycemic stimulus. Arginine infusion provoked a slightly above normal increase in blood glucose and a normal increase in blood glucagon. In three of the patients studied postoperatively, reduced glycemic response to glucose was observed, whereas there were no evident variations in blood insulin and glucagon response. These data suggest that in pheochromocytoma impaired glucose tolerance is partly due to the reduced insulin response to oral glucose load.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071824     DOI: 10.1007/BF03346795

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  Inhibition of insulin secretion by a phaeochromocytoma.

Authors:  J F Wilber; J R Turtle; N A Crane
Journal:  Lancet       Date:  1966-10-01       Impact factor: 79.321

2.  [Insulin secretion studied on isolated perfused rat pancreas. II. Effects of catecholamines and adrenergic blocking drugs].

Authors:  A Loubatières; M M Mariani; J Chapal
Journal:  Diabetologia       Date:  1970-12       Impact factor: 10.122

3.  Pheochromocytoma: observations on mechanism of carbohydrate intolerance and abnormalities associated with development of Goldblatt kidney following removal of tumor.

Authors:  M H Brooks; A Guha; E Danforth; J J Weinstein; K G Barry
Journal:  Metabolism       Date:  1969-06       Impact factor: 8.694

4.  Inhibition of insulin secretion by catecholamines in pheochromocytoma.

Authors:  J A Colwell
Journal:  Ann Intern Med       Date:  1969-08       Impact factor: 25.391

5.  Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade.

Authors:  J E Vance; K D Buchanan; D O'Hara; R H Williams; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

6.  Adrenergic mechanisms of catecholamine action on glucose homeostasis in man.

Authors:  R A Rizza; P E Cryer; M W Haymond; J E Gerich
Journal:  Metabolism       Date:  1980-11       Impact factor: 8.694

7.  Hormonal and metabolic studies in a patient with a pheochromocytoma.

Authors:  D M Turnbull; D G Johnston; K G Alberti; R Hall
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

8.  Epinephrine and the regulation of glucose metabolism: effect of diabetes and hormonal interactions.

Authors:  R S Sherwin; H Shamoon; R Hendler; L Saccà; N Eigler; M Walesky
Journal:  Metabolism       Date:  1980-11       Impact factor: 8.694

9.  Pancreatic alpha- and beta-cell function in pheochromocytoma.

Authors:  M Hamaji
Journal:  J Clin Endocrinol Metab       Date:  1979-09       Impact factor: 5.958

10.  Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma.

Authors:  G Stenström; L Sjöström; U Smith
Journal:  Acta Endocrinol (Copenh)       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.